Protalix Biotherapeutics Inc share price logo

Protalix Biotherapeutics Inc Share Price

NYSE: PLX

Small Cap

$2.15

+0.04

(+1.66%)

as on

Protalix Biotherapeutics Inc Stock Performance

as on March 28, 2026 at 6:59 am IST

  • Day's Low

    Day's High

    $2.09
    $2.21
    downward going graph

    2.79%

    Downside

    2.79%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.32
    $3.19
    downward going graph

    38.60%

    Downside

    48.37%

    Upside

    downward going graph

Protalix Biotherapeutics Inc share price movements today

Previous Close
$2.11
Open
$2.10
Volume
918.9K
Day's Low - High
$2.09 - $2.21
52 Week Low - High
$1.32 - $3.19

Protalix Biotherapeutics Inc Historical Returns

1 Month Return
-25.69 %
3 Month Return
+ 18.23 %
1 Year Return
-17.05 %
3 Year Return
+ 3.38 %
5 Year Return
0 %

Protalix Biotherapeutics Inc Stock Fundamentals & Key Indicators

Check Protalix Biotherapeutics Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$170.0M

EPS (TTM)

0.215

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

-0.01%

PE Ratio (TTM)

-4.56

Industry PE ratio

0

PEG Ratio

-0.1

EBITDA

-4.0M

Revenue (TTM)

52.7M

Profit Margin

-12.52%

Return On Equity TTM

-14.44%

Protalix Biotherapeutics Inc Stock Valuation

Track how Protalix Biotherapeutics Inc P/E has moved over time to understand its valuation trends.

Protalix Biotherapeutics Inc in the last 5 years

  • Overview

  • Trends

Lowest (-15.73x)

December 31, 2025

Industry (0.00x)

March 28, 2026

Today (-4.56x)

March 28, 2026

Highest (119.12x)

June 30, 2023

LowHigh

Today’s Price to Earnings Ratio: -4.56x

Protalix Biotherapeutics Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Protalix Biotherapeutics Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Protalix Biotherapeutics Inc image
Protalix Biotherapeutics Inc
BUY$170.0MNA-4.56-12.52%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$43.5B132.92%140.848.45%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$115.2B101.77%29.5832.94%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$31.8BNA112.585.37%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.0B54.69%18.2531.41%

Stock Returns calculator for Protalix Biotherapeutics Inc Stock including INR - Dollar returns

The Protalix Biotherapeutics Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Protalix Biotherapeutics Inc investment value today

Current value as on today

₹93,842

Returns

₹6,158

(-6.16%)

Returns from Protalix Biotherapeutics Inc Stock

₹16,667 (-16.67%)

Dollar Returns*

₹10,509 (+10.51%)

Analyst Recommendation on Protalix Biotherapeutics Inc Stock

Based on 5 analysts

BUY

80.00%

Buy

20.00%

Hold

0.00%

Sell

Based on 5 analysts, 80% of analysts recommend a 'BUY' rating for Protalix Biotherapeutics Inc. Average target price of $11

Protalix Biotherapeutics Inc Share Price Target

Get share price movements and forecasts by analysts on Protalix Biotherapeutics Inc.

What analysts predicted

80.45%UPSIDE

Target Price

$11

Current Price

$2.15

Analyzed by

5 Analysts

Target

$11.00

Protalix Biotherapeutics Inc target price $11, a slight upside of 80.45% compared to current price of $2.15. According to 5 analysts rating.

Protalix Biotherapeutics Inc Stock’s Investor Sentiment and Interest

Search interest for Protalix Biotherapeutics Inc Stock has decreased by -49% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-49% versus previous 30 day period

Protalix Biotherapeutics Inc Quarterly Profit & Loss

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Total Revenue
10
10
3
13
17
18
10
15
17
9
Gross Profit
5
1
1
4
9
14
1
9
9
4
Operating Income
-1
-5
-4
-2
3
7
-4
1
2
-4
EBITDA
0
-5
-4
-1
4
7
-3
1
2
-5
Interest Expense
0
0
0
0
0
0
0
0
0
0
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-1
-6
-4
-2
3
7
-3
0
2
-4
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-1
-6
-4
-2
3
6
-3
0
2
-5
Net Profit Margin
-17.90%
-57.64%
-122.60%
-16.35%
18.02%
35.65%
-35.79%
1.05%
13.19%
-60.34%

Protalix Biotherapeutics Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2016
Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
9
21
34
54
62
38
47
65
53
52
Gross Profit
0
5
24
43
52
22
28
42
29
25
Operating Income
-33
-34
-19
-10
2
-20
-13
10
3
-5
EBITDA
-23
-71
-17
-8
4
-18
-10
12
6
-4
Interest Expense
4
9
7
7
9
7
2
3
1
1
Depreciation
-
1
1
1
1
1
1
1
1
1
Income Before Tax
-29
-83
-26
-18
-6
-27
-14
8
4
-5
Income Tax Expense
10
7
0
7
8
6
0
0
1
0
Net Income
-29
-83
-26
-18
-6
-27
-14
8
2
-6
Net Profit Margin
-319.22%
-395.86%
-77.27%
-33.42%
-10.37%
-71.92%
-31.33%
12.69%
5.49%
-12.52%

Protalix Biotherapeutics Inc Quarterly Cash Flow

All numbers in Millions USD

Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Net Income
-6
-4
-2
3
6
-3
0
2
1
Operating Cash Flow
3
4
-3
4
3
-5
-5
-3
2
Investing Cash Flow
0
0
0
20
-15
0
0
0
-1
Financing Cash Flow
-
-
-
-20
3
5
4
9
0
Change in Cash
3
3
-3
4
-7
0
-1
-4
1

Protalix Biotherapeutics Inc Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-85
-26
-18
-6
-27
-14
8
2
-6
Operating Cash Flow
-9
-7
-19
-26
-10
-25
-1
8
-11
Investing Cash Flow
-1
0
0
-19
18
-5
-16
4
-2
Financing Cash Flow
-1
-4
46
46
12
8
24
-16
9
Change in Cash
-12
-13
-20
0
20
-21
6
-3
-4

Insights on Protalix Biotherapeutics Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 18.2% return, outperforming this stock by 35.3%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 68.3% return, outperforming this stock by 64.9%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, PLX stock has moved down by -25.7%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 2 quarters, 2.35M → -5.50M (in $), with an average decrease of 333.7% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 2 quarters, 17.85M → 9.12M (in $), with an average decrease of 48.9% per quarter

About Protalix Biotherapeutics Inc

protalix is a publicly traded, clinical stage biopharmaceutical company (nyse, tase: plx) focused on the development and commercialization of recombinant therapeutic proteins using its proprietary procellex™ plant cell culture protein expression system. procellex provides a unique platform on which we have established a pipeline of proprietary and biosimilar versions of recombinant therapeutic proteins, relying upon known biological mechanisms of action. protalix's lead product, taliglucerase-alfa is an enzyme replacement therapy for the treatment of gaucher´s disease. protalix has concluded phase iii studies for this drug and is currently undergoing fda review. treatment is currently being provided by protalix to gaucher patients under clinical studies and companionate programs to hundreds of patients worldwide. this product has been licensed to pfizer. protalix's pipeline includes multiple therapeutic protein candidates including: acetylcholinesterase (biodefense); alfa‐galactosidase
OrganisationProtalix Biotherapeutics Inc
Headquarters2 University Plaza, Hackensack, NJ, United States, 07601
IndustryHealth Services
CEOMr. Dror Bashan
E-voting on sharesClick here to vote

Key Management of Protalix Biotherapeutics Inc

Name

Title

Mr. Dror Bashan

President, CEO & Director

Mr. Yaron Naos B.Sc., MBA

Senior Vice President of Operations

Mr. Gilad Mamlok

Senior VP & CFO

Ms. Yael Fellous

Vice President of Human Resources

FAQs

What is Protalix Biotherapeutics Inc share price today?

Protalix Biotherapeutics Inc share price today is $2.15 as on at the close of the market. Protalix Biotherapeutics Inc share today touched a day high of $2.21 and a low of $2.09.

What is the 52 week high and 52 week low for Protalix Biotherapeutics Inc share?

Protalix Biotherapeutics Inc share touched a 52 week high of $3.19 on and a 52 week low of $1.32 on . Protalix Biotherapeutics Inc stock price today i.e. is closed at $2.15,which is 32.60% down from its 52 week high and 62.88% up from its 52 week low.

What is Protalix Biotherapeutics Inc's market capitalisation today?

Protalix Biotherapeutics Inc market capitalisation is $0.00T as on .

How to invest in Protalix Biotherapeutics Inc Stock (PLX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Protalix Biotherapeutics Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Protalix Biotherapeutics Inc Shares that will get you 0.6977 shares as per Protalix Biotherapeutics Inc share price of $2.15 per share as on March 28, 2026 at 1:29 am IST.

What is the minimum amount required to buy Protalix Biotherapeutics Inc Stock (PLX) from India?

Indian investors can start investing in Protalix Biotherapeutics Inc (PLX) shares with as little as ₹94.651 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹946.51 in Protalix Biotherapeutics Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Protalix Biotherapeutics Inc share’s latest price of $2.15 as on March 28, 2026 at 1:29 am IST, you will get 4.6512 shares of Protalix Biotherapeutics Inc. Learn more about fractional shares .